Received May 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 423NO | — |
Administration after a below temperature excursion of 29.9 degree F as the minimum reached.; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a female patient who received HAV (Havrix) (batch number 423NO) for prophylaxis. On an unknown date, the patient received Havrix. On an unknown date, an unknown time after receiving Havrix, the patient experienced incorrect storage of drug (Verbatim: Administration after a below temperature excursion of 29.9 degree F as the minimum reached.). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 21-MAY-2025 Other HCP reported after giving several vaccines that were exposed to a temperature of 29.9 degree F as the lowest reached for Havrix, which led to incorrect storage of drug.; Sender's Comments: US-GSK-US2025061548:same reporter,Different patient US-GSK-US2025061548:same reporter,Different patient US-GSK-US2025061546:Same reporter,Different patient